New Novartis data show Piqray effectiveness across key biomarkers in patients with HR+/HER2-… EP News Bureau Jun 6, 2022 Biomarker analysis from phase-III Solar-1 study shows Piqray plus fulvestrant had clinical benefit regardless of presence of ESR1…
